From the March 2017 issue of HealthCare Business News magazine
Let me finish with this:
• There were an estimated 1,165,210 new cancer cases in the U.S. in 2016.
• Approximately 60 percent of new cancer cases will receive radiation therapy.
• Approximately 20 percent or more of the 60 percent of new cases will be potential candidates for proton therapy treatment.
• By 2020, 33 percent of the world will be affected by cancer.
• Strong demand for smaller, more affordable, compact machines in the $30 million-to-$ 40 million range represent the future of proton therapy. This will likely put added pressure on the manufacturers to speed up production of equipment.
• There are 25 operating centers in the U.S. About a dozen more are in the pipeline.
• The VA-Stanford University Hadron Radiation Therapy Partnership in Palo Alto, Calif., will consist of proton beam radiation, research and the first carbon beam radiation therapy in the U.S. providing precision particle therapy services to our nation’s veterans and Stanford Medicine patients.
About the author: Len Arzt founded the National Association for Proton Therapy in 1989 and created the National Proton Conference in 2012. He retired as NAPT executive director in December 2014. Arzt is a consultant/senior advisor on the Stantec Architecture particle therapy team.Back to HCB News
